Stocktoria
Vericel Corp VCEL
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1997-02-04
Vericel Corp institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 8,056,828 | $369.6M |
| TWO SIGMA INVESTMENTS, LP | 485,012 | $15.6M |
| D. E. Shaw & Co., Inc. | 295,626 | $9.5M |
| Point72 Asset Management, L.P. | 164,000 | $5.3M |
| CITADEL ADVISORS LLC | 113,546 | $3.7M |
| AQR CAPITAL MANAGEMENT LLC | 48,690 | $1.6M |
| MILLENNIUM MANAGEMENT LLC | 13,849 | $445,522 |
| RENAISSANCE TECHNOLOGIES LLC | 12,600 | $405,342 |
Source: SEC EDGAR filings · CIK 0000887359 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.